Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12943-016-0502-x.

Title:
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications | Molecular Cancer
Description:
The epithelial to mesenchymal transition (EMT) is a biological process in which a non-motile epithelial cell changes to a mesenchymal phenotype with invasive capacities. This phenomenon has been well documented in multiple biological processes including embryogenesis, fibrosis, tumor progression and metastasis. The hallmark of EMT is the loss of epithelial surface markers, most notably E-cadherin, and the acquisition of mesenchymal markers including vimentin and N-cadherin. The downregulation of E-cadherin during EMT can be mediated by its transcriptional repression through the binding of EMT transcription factors (EMT-TFs) such as SNAIL, SLUG and TWIST to E-boxes present in the E-cadherin promoter. Additionally, EMT-TFs can also cooperate with several enzymes to repress the expression of E-cadherin and regulate EMT at the epigenetic and post- translational level. In this review, we will focus on epigenetic and post- translational modifications that are important in EMT. In addition, we will provide an overview of the various therapeutic approaches currently being investigated to undermine EMT and hence, the metastatic progression of cancer as well.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,625,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

pubmed, article, google, scholar, cas, cancer, emt, cell, expression, central, ecadherin, snail, cells, histone, transition, epithelial, protein, transcription, methylation, cdh, tumor, metastasis, breast, promoter, epithelialmesenchymal, epigenetic, mesenchymal, twist, genes, phosphorylation, results, regulation, modifications, proteins, dna, hdac, modification, gene, sumoylation, activation, target, biol, progression, sirt, transcriptional, zeb, human, development, hifα, important,

Topics {✒️}

tgfbeta-induced epithelial-mesenchymal transition hypoxia-induced epithelial-mesenchymal transition corepressor c-terminal-binding protein o-linked β-n-acetylglucosamine article serrano-gomez article download pdf uridine 5′-diphospho-n-acetylglucosamine e-cadherin invasion-suppressor gene α-ketoglutarate dependent demethylase snail-mediated e-cadherin repression e-cadherin-integrin crosstalk twist/mi2/nurd protein complex zeb/mir-200 feedback loop zeb/mir-200 feedback loop tgf-β activates kdm6b post-translational modifications represents o-linked n-acetylglucosaminylation mi 2/nurd/mta2 complex e3-ubiquitin ligase smurf-1 sentrin/sumo-specific proteases pdhs hydroxylate hif-1α zeb1 represses e-cadherin dna-binding domain called e-cadherin germline mutations tβri- tβrii hetero-dimerize hypoxia inducible factor-1 spindle-shaped cell morphology epithelial-mesenchymal transition process ferrell jr je genome-scale epigenetic reprogramming cell-cell contact proteins dna methylation-independent context e-cadherin gene expression de andrade jp process include n-cadherin regulates hif-1α degradation pkd1-fbxo11-snail axis smad-interacting protein 1 normal adult cells/tissues explore potential applications gsk-3beta-mediated phosphorylation oxygen-dependent degradation domain bhlh factor e2 post-translational modification characterized specific cell-surface proteins multi-protein complexes composed prevent e-cadherin expression privacy choices/manage cookies snai1-mediated transcriptional repression tyrosine kinase receptors

Questions {❓}

  • The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?
  • The relevance of EMT in breast cancer metastasis: Correlation or causality?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
         description:The epithelial to mesenchymal transition (EMT) is a biological process in which a non-motile epithelial cell changes to a mesenchymal phenotype with invasive capacities. This phenomenon has been well documented in multiple biological processes including embryogenesis, fibrosis, tumor progression and metastasis. The hallmark of EMT is the loss of epithelial surface markers, most notably E-cadherin, and the acquisition of mesenchymal markers including vimentin and N-cadherin. The downregulation of E-cadherin during EMT can be mediated by its transcriptional repression through the binding of EMT transcription factors (EMT-TFs) such as SNAIL, SLUG and TWIST to E-boxes present in the E-cadherin promoter. Additionally, EMT-TFs can also cooperate with several enzymes to repress the expression of E-cadherin and regulate EMT at the epigenetic and post- translational level. In this review, we will focus on epigenetic and post- translational modifications that are important in EMT. In addition, we will provide an overview of the various therapeutic approaches currently being investigated to undermine EMT and hence, the metastatic progression of cancer as well.
         datePublished:2016-02-24T00:00:00Z
         dateModified:2016-02-24T00:00:00Z
         pageStart:1
         pageEnd:14
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12943-016-0502-x
         keywords:
            Cancer
            Metastasis
            Epigenetic
            Methylation
            Therapy
            Cancer Research
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-016-0502-x/MediaObjects/12943_2016_502_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-016-0502-x/MediaObjects/12943_2016_502_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-016-0502-x/MediaObjects/12943_2016_502_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-016-0502-x/MediaObjects/12943_2016_502_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-016-0502-x/MediaObjects/12943_2016_502_Fig5_HTML.gif
         isPartOf:
            name:Molecular Cancer
            issn:
               1476-4598
            volumeNumber:15
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Silvia Juliana Serrano-Gomez
               affiliation:
                     name:LSUHSC School of Medicine
                     address:
                        name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
                        type:PostalAddress
                     type:Organization
                     name:Pontificia Universidad Javeriana
                     address:
                        name:Pontificia Universidad Javeriana, Bogota, Colombia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mazvita Maziveyi
               affiliation:
                     name:LSUHSC School of Medicine
                     address:
                        name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Suresh K. Alahari
               affiliation:
                     name:LSUHSC School of Medicine
                     address:
                        name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
      description:The epithelial to mesenchymal transition (EMT) is a biological process in which a non-motile epithelial cell changes to a mesenchymal phenotype with invasive capacities. This phenomenon has been well documented in multiple biological processes including embryogenesis, fibrosis, tumor progression and metastasis. The hallmark of EMT is the loss of epithelial surface markers, most notably E-cadherin, and the acquisition of mesenchymal markers including vimentin and N-cadherin. The downregulation of E-cadherin during EMT can be mediated by its transcriptional repression through the binding of EMT transcription factors (EMT-TFs) such as SNAIL, SLUG and TWIST to E-boxes present in the E-cadherin promoter. Additionally, EMT-TFs can also cooperate with several enzymes to repress the expression of E-cadherin and regulate EMT at the epigenetic and post- translational level. In this review, we will focus on epigenetic and post- translational modifications that are important in EMT. In addition, we will provide an overview of the various therapeutic approaches currently being investigated to undermine EMT and hence, the metastatic progression of cancer as well.
      datePublished:2016-02-24T00:00:00Z
      dateModified:2016-02-24T00:00:00Z
      pageStart:1
      pageEnd:14
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12943-016-0502-x
      keywords:
         Cancer
         Metastasis
         Epigenetic
         Methylation
         Therapy
         Cancer Research
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-016-0502-x/MediaObjects/12943_2016_502_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-016-0502-x/MediaObjects/12943_2016_502_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-016-0502-x/MediaObjects/12943_2016_502_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-016-0502-x/MediaObjects/12943_2016_502_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-016-0502-x/MediaObjects/12943_2016_502_Fig5_HTML.gif
      isPartOf:
         name:Molecular Cancer
         issn:
            1476-4598
         volumeNumber:15
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Silvia Juliana Serrano-Gomez
            affiliation:
                  name:LSUHSC School of Medicine
                  address:
                     name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
                     type:PostalAddress
                  type:Organization
                  name:Pontificia Universidad Javeriana
                  address:
                     name:Pontificia Universidad Javeriana, Bogota, Colombia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mazvita Maziveyi
            affiliation:
                  name:LSUHSC School of Medicine
                  address:
                     name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Suresh K. Alahari
            affiliation:
                  name:LSUHSC School of Medicine
                  address:
                     name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Cancer
      issn:
         1476-4598
      volumeNumber:15
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:LSUHSC School of Medicine
      address:
         name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
         type:PostalAddress
      name:Pontificia Universidad Javeriana
      address:
         name:Pontificia Universidad Javeriana, Bogota, Colombia
         type:PostalAddress
      name:LSUHSC School of Medicine
      address:
         name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
         type:PostalAddress
      name:LSUHSC School of Medicine
      address:
         name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Silvia Juliana Serrano-Gomez
      affiliation:
            name:LSUHSC School of Medicine
            address:
               name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
               type:PostalAddress
            type:Organization
            name:Pontificia Universidad Javeriana
            address:
               name:Pontificia Universidad Javeriana, Bogota, Colombia
               type:PostalAddress
            type:Organization
      name:Mazvita Maziveyi
      affiliation:
            name:LSUHSC School of Medicine
            address:
               name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
               type:PostalAddress
            type:Organization
      name:Suresh K. Alahari
      affiliation:
            name:LSUHSC School of Medicine
            address:
               name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
      name:Pontificia Universidad Javeriana, Bogota, Colombia
      name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA
      name:Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, USA

External Links {🔗}(505)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.29s.